Resources Contact Us Home
Internalizing anti-CD74 antibodies and methods of use

Image Number 15 for United States Patent #7931903.

The present invention provides humanized, chimeric and human anti-CD74 antibodies, CD74 antibody fusion proteins, immunoconjugates, vaccines and bispecific that bind to CD74, the major histocompatibility complex (MHC) class-II invariant chain, Ii, which is useful for the treatment and diagnosis of B-cell disorders, such as B-cell malignancies, other malignancies in which the cells are reactive with CD74, and autoimmune diseases, and methods of treatment and diagnosis.

  Recently Added Patents
Image processing apparatus, image display apparatus, and image processing method
Metal melting apparatus and method for melting metal
Film-forming resins as a carrier for topical application of pharmacologically active agents
Methods and system for displaying segmented images
Method for cutting C--Mn steel with a fiber laser
Automatic pill dispenser
  Randomly Featured Patents
Vapor deposition apparatus and vapor deposition method
Rotary internal combustion engine and rotary internal combustion engine cycle
Apparatus for encapsulating radio frequency identification (RFID) antennae
Electromagnetic therapeutic treatment device and methods of using same
Biodegradable polymer composition
Operating a coupling channel in a plurality of modes
Cooling apparatus for electronic device
Doped stoichiometric lithium niobate crystals and method for high-speed holographic data storage
Pipe support and hanger system and method of making
Method of fabricating quantum wire